Cargando…

Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson's Disease

Objectives. This open-label study assessed the efficacy and safety of exclusive night-time administration of transdermal rotigotine in patients with nocturnal and early morning PD symptoms. Methods. Patients with PD and nocturnal and early morning symptoms received transdermal rotigotine patches (2–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallderiola, Francesc, Compta, Yaroslau, Aparicio, Javier, Tarradellas, Jaume, Salazar, Gabriel, Oliver, Josep María, Callén, Antonio, Delgado, Tania, Nobbe, Fritz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632005/ https://www.ncbi.nlm.nih.gov/pubmed/26576319 http://dx.doi.org/10.1155/2015/475630

Ejemplares similares

Transdermal rotigotine for the perioperative management of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2010)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
por: Pagonabarraga, Javier, et al.
Publicado: (2015)

Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism
por: Moretti, Davide Vito, et al.
Publicado: (2014)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

Delirious episode secondary to rotigotine: the psychotic patch
por: Andreo Vidal, M. A., et al.
Publicado: (2023)

Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation
por: Ogawa, Takashi, et al.
Publicado: (2018)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer
por: Barrantes, Sergi, et al.
Publicado: (2017)

Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease
por: Kim, Han-Joon, et al.
Publicado: (2011)

Rotigotine Transdermal Patch in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Zhou, Chang-Qing, et al.
Publicado: (2013)

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
por: Hauser, Robert A, et al.
Publicado: (2016)

A Systematic Review of the Usage of Rotigotine During Early and Advanced Stage Parkinson's
por: Rajendran, Avanthika, et al.
Publicado: (2023)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy
por: Moretti, Davide Vito, et al.
Publicado: (2014)

Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study
por: Wang, Aiping, et al.
Publicado: (2016)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording
por: Calandra-Buonaura, Giovanna, et al.
Publicado: (2016)

Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
por: Bi, Chenchen, et al.
Publicado: (2016)

Vascular parkinsonism sensitive to rotigotine therapy is found in aged patients: a clinical case description
por: Zarola, Flora
Publicado: (2018)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Nocturnal Pruritus: The Battle for a Peaceful Night’s Sleep
por: Lavery, Michael Joseph, et al.
Publicado: (2016)

Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment
por: Oltra, Javier, et al.
Publicado: (2022)

Rotigotine transdermal system: a short review
por: Bunten, Sabine, et al.
Publicado: (2006)

Levodopa/rotigotine: Lack of efficacy: case report
Publicado: (2022)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021)

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017)

Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson’s disease: an open-label study
por: Kim, Jong-Min, et al.
Publicado: (2015)

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations
por: Kesayan, Tigran, et al.
Publicado: (2015)

Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorder
por: Oltra, Javier, et al.
Publicado: (2021)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

The Night Effect of Anger: Relationship with Nocturnal Blood Pressure Dipping
por: Casagrande, Maria, et al.
Publicado: (2020)

Restless legs syndrome: differential diagnosis and management with rotigotine
por: Merlino, Giovanni, et al.
Publicado: (2009)

Transdermal rotigotine for the perioperative management of restless legs syndrome
por: Högl, Birgit, et al.
Publicado: (2012)

EHMTI-0081. Use of rotigotine in chronic cluster headache
por: Savi, L, et al.
Publicado: (2014)

Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study
por: Kassubek, Jan, et al.
Publicado: (2014)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2016)

Critical appraisal of rotigotine transdermal system in management of Parkinson’s disease and restless legs syndrome – patient considerations [Corrigendum]
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jn66mrj5p9crj8b2262q0ojv4i